| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968251 | Vaccine | 2012 | 11 Pages |
Abstract
⺠In low endemic countries, risks of extended HAV outbreaks are a cause for concern. ⺠Vaccination targeting adults could be an alternative to childhood vaccination. ⺠Such a strategy is not cost-effective as it would cost 185,000⬠per QALY. ⺠Screening first and vaccination of seronegatives would cost 223,000⬠per QALY. ⺠To be cost-effective risk-groups require a 3.5-4 times higher force of infection.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jeroen Luyten, Stefaan Van de Sande, Koen de Schrijver, Pierre Van Damme, Philippe Beutels,